Analysis of Resistance to Clarithromycin and Virulence Markers in Helicobacter pylori Clinical Isolates from Eastern Taiwan

Tzu Chi Medical Journal

Volumn 21, Issue 2, 2009, Pages 123-128

  Hu, Chi Tan ^a,b   Chiou, Pei Yu ^b   Wu, Chao Chuan ^a   Tseng, Yi Hsiung ^c   Chang, Yao Jen ^a   Lin, Nien Tsung ^b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Clarithromycin resistant; Genotyping; Helicobacter pylori; Virulence marker

Indexed keywords

ADENINE; CAGA PROTEIN; CLARITHROMYCIN; CYTOSINE; DNA 23S; GUANINE; ICEA PROTEIN; THREONINE; UNCLASSIFIED DRUG; VACUOLATING TOXIN; VIRULENCE FACTOR;

ADULT; ALLELE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CHRONIC GASTRITIS; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENOTYPE; HELICOBACTER PYLORI; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PEPTIC ULCER; POINT MUTATION; POLYMERASE CHAIN REACTION; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; TAIWAN; WILD TYPE;

EID: 66449106611     PISSN: 10163190     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1016-3190(09)60023-9     Document Type: Article

References (44)

1. Dunn B.E., Cohen H., and Blaser M.J. Helicobacter pylori. Clin Microbiol Rev 10 (1997) 720-741
2. Taylor D.N., and Parsonnet J. Epidemiology and natural history of H. pylori infections. In: Blaser M.J., Smith P.F., Ravdin J., Greenberg H., and Guerrant R.L. (Eds). Infections of the Gastrointestinal Tract (1995), Raven, New York 551-564
3. Graham D.Y., Lew G.M., Klein P.D., et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 116 (1992) 705-708
4. Parsonnet J., Hansen S., Rodriguez L., et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330 (1994) 1267-1271
5. Forman D., Webb P., and Parsonnet J. H pylori and gastric cancer. Lancet 343 (1994) 243-244
6. Parsonnet J. Gastric adenocarcinoma and Helicobacter pylori infection. West J Med 161 (1994) 60
7. Sipponen P. Helicobacter pylori and chronic gastritis: an increased risk of peptic ulcer? A review. Scand J Gastroenterol Suppl 186 (1991) 6-10
8. Hu C.T., Wu C.C., Lin C.Y., et al. Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan. J Gastroenterol Hepatol 22 (2007) 720-723
9. Versalovic J., Shortridge D., Kibler K., et al. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother 40 (1996) 477-480
10. Taylor D.E., Ge Z., Purych D., Lo T., and Hiratsuka K. Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob Agents Chemother 41 (1997) 2621-2628
11. Occhialini A., Urdaci M., Doucet-Populaire F., Bebear C.M., Lamouliatte H., and Megraud F. Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes. Antimicrob Agents Chemother 41 (1997) 2724-2728
12. Stone G.G., Shortridge D., Flamm R.K., et al. Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori. Helicobacter 1 (1996) 227-228
13. Hulten K., Gibreel A., Skold O., and Engstrand L. Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients. Antimicrob Agents Chemother 41 (1997) 2550-2553
14. Kim K.S., Kang J.O., Eun C.S., Han D.S., and Choi T.Y. Mutations in the 23S rRNA gene of Helicobacter pylori associated with clarithromycin resistance. J Korean Med Sci 17 (2002) 599-603
15. Toracchio S., Aceto G.M., Mariani-Costantini R., Battista P., and Marzio L. Identification of a novel mutation affecting domain V of the 23S rRNA gene in Helicobacter pylori. Helicobacter 9 (2004) 396-399
16. van Doorn L.J., Figueiredo C., Sanna R., et al. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 115 (1998) 58-66
17. Wu C.C., Chou P.Y., Hu C.T., et al. Clinical relevance of the vacA, iceA, cagA, and flaA genes of Helicobacter pylori strains isolated in Eastern Taiwan. J Clin Microbiol 43 (2005) 2913-2915
18. Covacci A., Censini S., Bugnoli M., et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 90 (1993) 5791-5795
19. Atherton J.C., Peek Jr. R.M., Tham K.T., Cover T.L., and Blaser M.J. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 112 (1997) 92-99
20. Elviss N.C., Owen R.J., Xerry J., Walker A.M., and Davies K. Helicobacter pylori antibiotic resistance patterns and genotypes in adult dyspeptic patients from a regional population in North Wales. J Antimicrob Chemother 54 (2004) 435-440
21. Yakoob J., Fan X., Hu G., and Zhang Z. Genetic and phenotype changes following in vitro interactions between Helicobacter pylori strains. J Gastroenterol Hepatol 19 (2004) 626-631
22. Stege P.W., and Vega A.E. Analysis of resistance to clarithromycin and iceA status in Helicobacter pylori isolates from San Luis, Argentina. Int J Antimicrob Agents 28 (2006) 477-478
23. Cellini L., Grande R., Di Campli E., Di Bartolomeo S., Capodicasa S., and Marzio L. Analysis of genetic variability, antimicrobial susceptibility and virulence markers in Helicobacter pylori identified in Central Italy. Scand J Gastroenterol 41 (2006) 280-287
24. Akopyanz N., Bukanov N.O., Westblom T.U., and Berg D.E. PCR-based RFLP analysis of DNA sequence diversity in the gastric pathogen Helicobacter pylori. Nucleic Acids Res 20 (1992) 6221-6225
25. Pena J.A., Fox J.G., Ferraro M.J., and Versalovic J. Molecular resistance testing of Helicobacter pylori in gastric biopsies. Arch Pathol Lab Med 125 (2001) 493-497
26. Megraud F. H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 53 (2004) 1374-1384
27. Fallone C.A. Epidemiology of the antibiotic resistance of Helicobacter pylori in Canada. Can J Gastroenterol 14 (2000) 879-882
28. Osato M.S., Reddy R., Reddy S.G., Penland R.L., Malaty H.M., and Graham D.Y. Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States. Arch Intern Med 161 (2001) 1217-1220
29. Mohammadi M., Doroud D., Massarrat S., and Farahvash M.J. Clarithromycin resistance in Iranian H. pylori strains before introduction of clarithromycin. Helicobacter 8 (2003) 80
30. Samra Z., Shmuely H., Niv Y., et al. Resistance of Helicobacter pylori isolated in Israel to metronidazole, clarithromycin, tetracycline, amoxicillin and cefixime. J Antimicrob Chemother 49 (2002) 1023-1026
31. Kato M., Yamaoka Y., Kim J.J., et al. Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan. Antimicrob Agents Chemother 44 (2000) 2214-2216
32. Yang Y.J., Yang J.C., Jeng Y.M., Chang M.H., and Ni Y.H. Prevalence and rapid identification of clarithromycin-resistant Helicobacter pylori isolates in children. Pediatr Infect Dis J 20 (2001) 662-666
33. Huang A.H., Sheu B.S., Yang H.B., Huang C.C., Wu J.J., and Lin X.Z. Impact of Helicobacter pylori antimicrobial resistance on the outcome of 1-week lansoprazole-based triple therapy. J Formos Med Assoc 99 (2000) 704-709
34. Ling T.K., Leung W.K., Lee C.C., et al. The antimicrobial susceptibility of Helicobacter pylori in Hong Kong (1997-2001). Helicobacter 7 (2002) 327-328
35. Kim J.J., Reddy R., Lee M., et al. Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J Antimicrob Chemother 47 (2001) 459-461
36. van Doorn L.J., Debets-Ossenkopp Y.J., Marais A., et al. Rapid detection, by PCR and reverse hybridization, of mutations in the Helicobacter pylori 23S rRNA gene, associated with macrolide resistance. Antimicrob Agents Chemother 43 (1999) 1779-1782
37. Hao Q., Li Y., Zhang Z.J., Liu Y., and Gao H. New mutation points in 23S rRNA gene associated with Helicobacter pylori resistance to clarithromycin in northeast China. World J Gastroenterol 10 (2004) 1075-1077
38. Versalovic J., Osato M.S., Spakovsky K., et al. Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J Antimicrob Chemother 40 (1997) 283-286
39. Stone G.G., Shortridge D., Versalovic J., et al. A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. Antimicrob Agents Chemother 41 (1997) 712-714
40. Alarcon T., Domingo D., Prieto N., and Lopez-Brea M. Clarithromycin resistance stability in Helicobacter pylori: influence of the MIC and type of mutation in the 23S rRNA. J Antimicrob Chemother 46 (2000) 613-616
41. van Doorn L.J., Glupczynski Y., Kusters J.G., et al. Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. Antimicrob Agents Chemother 45 (2001) 1500-1504
42. Kato S., Fujimura S., Udagawa H., et al. Antibiotic resistance of Helicobacter pylori strains in Japanese children. J Clin Microbiol 40 (2002) 649-653
43. Pan Z.J., Su W.W., Tytgat G.N., Dankert J., and van der Ende A. Assessment of clarithromycin-resistant Helicobacter pylori among patients in Shanghai and Guangzhou, China, by primer-mismatch PCR. J Clin Microbiol 40 (2002) 259-261
44. Vester B., and Douthwaite S. Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob Agents Chemother 45 (2001) 1-12